Targeting specific gene fusions that drive aggressive sarcomas
Leveraging Retained Partner Gene Function to Effectively Target CIC-rearranged Fusion Oncoproteins
This study is looking at how specific gene changes, especially involving the CIC gene, might lead to aggressive sarcomas, with the goal of finding better treatments for patients facing this condition.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10995787 on NIH RePORTER |
What this research studies
This research investigates how certain gene fusions, particularly involving the Capicua (CIC) gene, contribute to the development of aggressive sarcomas. By understanding the biological mechanisms behind these fusions, the project aims to identify more effective treatment strategies. The researchers will utilize advanced techniques, including dynamic microscopy and patient-derived cell lines, to study the behavior of these fusion proteins in a laboratory setting. This approach seeks to uncover how these proteins function and how they can be targeted for therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with aggressive sarcomas that involve CIC gene fusions.
Not a fit: Patients with sarcomas not associated with CIC gene fusions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with aggressive sarcomas caused by CIC gene fusions.
How similar studies have performed: While research on CIC gene fusions is limited, similar approaches targeting specific oncogenic fusions have shown promise in other cancer types.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Luck, Cuyler — University of California, San Francisco
- Study coordinator: Luck, Cuyler
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.